CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf

CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf

ID:53739931

大?。?82.95 KB

頁數(shù):5頁

時(shí)間:2020-04-21

CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf_第1頁
CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf_第2頁
CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf_第3頁
CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf_第4頁
CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf_第5頁
資源描述:

《CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在應(yīng)用文檔-天天文庫。

1、第23071卷4年第6月3期遵義醫(yī)學(xué)院學(xué)報(bào)V01.37No.3JournalofZunyiMedicalUniversityJun.2014CIK逆轉(zhuǎn)耐順鉑人肺腺癌細(xì)胞對順鉑耐藥與ERCC1的相關(guān)性田昕,李寧,李冉(遵義醫(yī)學(xué)院附屬腫瘤醫(yī)院胸部腫瘤科,貴州遵義563099)[摘要]目的觀察臍血來源的CIK細(xì)胞對A549/DDP細(xì)胞的耐藥逆轉(zhuǎn)作用。并探討CIK逆轉(zhuǎn)耐藥機(jī)制是否與核苷酸切除修復(fù)交叉互補(bǔ)基因1(excisionrepaircrosscomplementationgroup1,ERCC1)的

2、表達(dá)存在相關(guān)性。方法采集臍血單個(gè)核細(xì)胞經(jīng)細(xì)胞因子體外誘導(dǎo)獲得CIK細(xì)胞(cytokineinducedkillerceils,CIK),MIrr法檢測順鉑(cisplatin,DDP)對A549細(xì)胞和A549/DDP細(xì)胞的體外殺傷作用,以及CIK細(xì)胞與A549/DDP細(xì)胞共培養(yǎng)前后對DDP敏感性的變化。Real—timeRT—PCR法檢測A549細(xì)胞、A549/DDP細(xì)胞以及CIK干預(yù)后的A549/DDP細(xì)胞中ERCC1mRNA的表達(dá)情況。Westernblot法檢測A549細(xì)胞、A549/DDP

3、細(xì)胞以及CIK干預(yù)后的A549/DDP細(xì)胞中ERCC1蛋白的表達(dá)情況。結(jié)果A549/DDP細(xì)胞對DDP耐藥,耐藥指數(shù)為2.391。CIK細(xì)胞能逆轉(zhuǎn)A549/DDP細(xì)胞對DDP的耐藥性,逆轉(zhuǎn)倍數(shù)為3.967。Real—timeRT—PCR、West—ernblot測得A549/DDP細(xì)胞中ERCC1mRNA和蛋白表達(dá)量比A549細(xì)胞高(P<0.05),CIK細(xì)胞共培養(yǎng)前后A549/DDP細(xì)胞中ERCC1mRNA和蛋白表達(dá)量無明顯變化。結(jié)論CIK細(xì)胞能逆轉(zhuǎn)A549/DDP細(xì)胞對DDP的耐藥性,其逆轉(zhuǎn)耐

4、藥的機(jī)制與ERCC1的表達(dá)無明顯相關(guān)性。[關(guān)鍵詞]肺癌;A549細(xì)胞;順鉑;耐藥逆轉(zhuǎn);CIK細(xì)胞[中圖法分類號]R734.2[文獻(xiàn)標(biāo)志碼]A[文章編號]1000—2715(2014)03-0338-05StudyonthecorrelationbetweenERCC1andthemerchanismsunderlyingcy·tokineinducedkillercells——reversedcisplatinresistanceinA549/DDPCellsTianXin,LNing,LiRan

5、(DepartmentofThoracic,TheAffiliatedHospitalofZunyiMedicalUniversity,ZunyiGuizhou563099,China)[Abstract]ObjectiveToinvestigatetheeffectsofcordblood—derivedcytokine—inducedkiller(CIK)cellsonreversingcisplatinresistanceintheDDP——resistanthumanlungadenoca

6、rcinomacelllineA549/DDPandobservewhethertherewascorrelationbetweentheseeffectsandexcisionrepaircrosscomplementationgroup1(ERCC1)expression.MethodsThesingleumbilicalcordbloodmononuclearcellwasinducedbycytokineinvitrotobe—comeCIKcells.MTFassaywasapplied

7、toevaluatethecytotoxicactivityofDDPagainstA549/DDPcellsandA549cellsinvitroandthesensitivityofA549/DDPcellsCIKtoDDPbeforeandaftertheco—culturewithCIK.ThemRNAandproteinexpressionsofERCC1inA549cells。A549/DDPcellsandA549/DDPco—culturedwithCIKcellsweredete

8、ctedbyreal—timeRT—PCRandwesternblotanalysis.ResultsTheA549/DDPcellswasresistanttoDDPwiththeresistanceindexof2.391.CIKcellsdecreaseddrugresistancetocisplatinwiththere.versalfoldof3.967.TheERCC1mRNAandproteinexprossionswerehigherinA549/DDPthanth

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負(fù)責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時(shí)聯(lián)系客服。
3. 下載前請仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請聯(lián)系客服處理。